Perigon Wealth Management LLC Buys Shares of 6,532 Ventas, Inc. $VTR

Perigon Wealth Management LLC purchased a new position in Ventas, Inc. (NYSE:VTRFree Report) during the 2nd quarter, Holdings Channel reports. The fund purchased 6,532 shares of the real estate investment trust’s stock, valued at approximately $580,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Dynamic Wealth Strategies LLC bought a new stake in shares of Ventas during the 1st quarter valued at $25,000. Wiser Advisor Group LLC bought a new position in Ventas in the 3rd quarter worth $27,000. IFC & Insurance Marketing Inc. bought a new position in Ventas in the 4th quarter worth $30,000. Elyxium Wealth LLC purchased a new position in Ventas during the fourth quarter valued at $33,000. Finally, Reflection Asset Management purchased a new position in Ventas during the fourth quarter valued at $34,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on VTR shares. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $100.00 price target on shares of Ventas in a research report on Tuesday, June 16th. Raymond James Financial assumed coverage on Ventas in a research report on Tuesday, June 16th. They set an “outperform” rating and a $94.00 price objective on the stock. Jefferies Financial Group boosted their price objective on Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Evercore reissued an “outperform” rating and issued a $95.00 target price on shares of Ventas in a report on Wednesday, April 29th. Finally, JPMorgan Chase & Co. raised their target price on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Monday, May 11th. Fifteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $98.00.

View Our Latest Stock Analysis on VTR

Ventas Price Performance

NYSE:VTR opened at $91.81 on Thursday. The business’s 50-day moving average is $91.00 and its 200 day moving average is $86.93. Ventas, Inc. has a 12 month low of $66.38 and a 12 month high of $101.60. The company has a market capitalization of $47.09 billion, a P/E ratio of 170.02, a P/E/G ratio of 2.10 and a beta of 0.69. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86.

Ventas (NYSE:VTRGet Free Report) last released its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The business had revenue of $1.73 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter last year, the business posted $0.87 EPS. The firm’s revenue for the quarter was up 21.7% compared to the same quarter last year. On average, equities research analysts forecast that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

Insider Activity at Ventas

In other news, Director Michael J. Embler bought 2,500 shares of the stock in a transaction dated Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the transaction, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.53% of the company’s stock.

Ventas Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Featured Articles

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTRFree Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.